Ahmed Hamdy, Vincerx CEO
Bear market hits another small cap biotech as Ahmed Hamdy's Vincerx cuts a third of staff
The biotech bear market continues to put pressure on small and mid-cap companies, with another startup undergoing a shift.
Cancer-focused biotech Vincerx revealed it would …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.